Paula de la Matta Farrando , Maria Teresa Suay Torres , Anna Sabater Sabaté , Victoria Trenchs Sainz de la Maza , Carles Luaces Cubells , Susanna Hernández Bou
{"title":"对FebriDx®治疗发热性急性呼吸道感染患儿的评估","authors":"Paula de la Matta Farrando , Maria Teresa Suay Torres , Anna Sabater Sabaté , Victoria Trenchs Sainz de la Maza , Carles Luaces Cubells , Susanna Hernández Bou","doi":"10.1016/j.eimc.2024.01.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Acute respiratory infections (ARI) are a common cause of inappropriate antibiotic prescription (ATB) in pediatrics. FebriDx® is a rapid diagnostic test that differentiates between viral and bacterial infections. The objective is to analyse the impact of FebriDx® on ATB prescription when managing febrile ARI.</p></div><div><h3>Methods</h3><p>Prospective study carried out in patients aged 1-<<!--> <!-->18 years with febrile ARI in the emergency department. FebriDx® was performed and the impact on management was evaluated at follow-up.</p></div><div><h3>Results</h3><p>A total of 216 patients were included. Clinical assessment and FebriDx® result coincided in 174 (80.5%) cases. A modification of the initial therapeutic plan was made in 22 (52.4%) of the 42 discordant ones (10.2% of the overall patients). In pneumonia the impact was 34.5%; in all cases it involved not prescribing ATB.</p></div><div><h3>Conclusion</h3><p>FebriDx® could be a useful tool in the management of pediatric patients with febrile ARI to optimize ATB prescription.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 6","pages":"Pages 313-316"},"PeriodicalIF":2.6000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluación de FebriDx® para el manejo de niños con infección respiratoria aguda febril\",\"authors\":\"Paula de la Matta Farrando , Maria Teresa Suay Torres , Anna Sabater Sabaté , Victoria Trenchs Sainz de la Maza , Carles Luaces Cubells , Susanna Hernández Bou\",\"doi\":\"10.1016/j.eimc.2024.01.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Acute respiratory infections (ARI) are a common cause of inappropriate antibiotic prescription (ATB) in pediatrics. FebriDx® is a rapid diagnostic test that differentiates between viral and bacterial infections. The objective is to analyse the impact of FebriDx® on ATB prescription when managing febrile ARI.</p></div><div><h3>Methods</h3><p>Prospective study carried out in patients aged 1-<<!--> <!-->18 years with febrile ARI in the emergency department. FebriDx® was performed and the impact on management was evaluated at follow-up.</p></div><div><h3>Results</h3><p>A total of 216 patients were included. Clinical assessment and FebriDx® result coincided in 174 (80.5%) cases. A modification of the initial therapeutic plan was made in 22 (52.4%) of the 42 discordant ones (10.2% of the overall patients). In pneumonia the impact was 34.5%; in all cases it involved not prescribing ATB.</p></div><div><h3>Conclusion</h3><p>FebriDx® could be a useful tool in the management of pediatric patients with febrile ARI to optimize ATB prescription.</p></div>\",\"PeriodicalId\":11608,\"journal\":{\"name\":\"Enfermedades infecciosas y microbiologia clinica\",\"volume\":\"42 6\",\"pages\":\"Pages 313-316\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Enfermedades infecciosas y microbiologia clinica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0213005X24001988\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24001988","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Evaluación de FebriDx® para el manejo de niños con infección respiratoria aguda febril
Introduction
Acute respiratory infections (ARI) are a common cause of inappropriate antibiotic prescription (ATB) in pediatrics. FebriDx® is a rapid diagnostic test that differentiates between viral and bacterial infections. The objective is to analyse the impact of FebriDx® on ATB prescription when managing febrile ARI.
Methods
Prospective study carried out in patients aged 1-< 18 years with febrile ARI in the emergency department. FebriDx® was performed and the impact on management was evaluated at follow-up.
Results
A total of 216 patients were included. Clinical assessment and FebriDx® result coincided in 174 (80.5%) cases. A modification of the initial therapeutic plan was made in 22 (52.4%) of the 42 discordant ones (10.2% of the overall patients). In pneumonia the impact was 34.5%; in all cases it involved not prescribing ATB.
Conclusion
FebriDx® could be a useful tool in the management of pediatric patients with febrile ARI to optimize ATB prescription.
期刊介绍：
Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
